Leila Alland's most recent trade in Abeona Therapeutics Inc was a trade of 11,000 Common Stock done at an average price of $5.9 . Disclosure was reported to the exchange on June 30, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Abeona Therapeutics Inc | Leila Alland | Director | Sale of securities on an exchange or to another person at price $ 5.92 per share. | 30 Jun 2026 | 11,000 | 162,614 (0%) | 0% | 5.9 | 65,087 | Common Stock |
| Abeona Therapeutics Inc | Leila Alland | Director | Sale of securities on an exchange or to another person at price $ 5.09 per share. | 02 Feb 2026 | 18,065 | 173,614 (0%) | 0% | 5.1 | 91,962 | Common Stock |
| Abeona Therapeutics Inc | Leila Alland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2026 | 37,313 | 191,679 (0%) | 0% | 0 | Common Stock | |
| Abeona Therapeutics Inc | Leila Alland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 36,101 | 154,366 (0%) | 0% | 0 | Common Stock | |
| Abeona Therapeutics Inc | Leila Alland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2024 | 11,797 | 118,265 (0%) | 0% | 0 | Common Stock | |
| Abeona Therapeutics Inc | Leila Alland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2024 | 23,611 | 106,468 (0%) | 0% | 0 | Common Stock | |
| Abeona Therapeutics Inc | Leila Alland | Director | Purchase of securities on an exchange or from another person at price $ 4.71 per share. | 16 May 2024 | 11,000 | 82,857 (0%) | 0% | 4.7 | 51,799 | Common Stock |
| Abeona Therapeutics Inc | Leila Alland | Director | Grant, award, or other acquisition of securities at price $ 4.62 per share. | 14 Jun 2023 | 58,689 | 79,103 (0%) | 0% | 4.6 | 271,143 | Common Stock |
| PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Abeona Therapeutics Inc | Leila Alland | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Sep 2022 | 13,400 | 20,414 (0%) | 0% | 0 | Common Stock | |
| PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2022 | 52,200 | 52,200 | - | 0 | Common Stock | |
| PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 104,400 | 104,400 | - | - | Employee Stock Option (right to buy) | |
| PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 30.25 per share. | 09 Sep 2021 | 100 | 0 | - | 30.3 | 3,025 | Common Stock |
| PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2021 | 100 | 353,850 | - | - | Employee Stock Option (right to buy) | |
| PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.90 per share. | 09 Sep 2021 | 100 | 100 | - | 3.9 | 390 | Common Stock |
| PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 30.25 per share. | 07 Sep 2021 | 3,900 | 0 | - | 30.3 | 117,975 | Common Stock |
| PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Sep 2021 | 3,900 | 353,950 | - | - | Employee Stock Option (right to buy) | |
| PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.90 per share. | 07 Sep 2021 | 3,900 | 3,900 | - | 3.9 | 15,210 | Common Stock |
| PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2021 | 4,000 | 357,850 | - | - | Employee Stock Option (right to buy) | |
| PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.90 per share. | 09 Aug 2021 | 4,000 | 4,000 | - | 3.9 | 15,600 | Common Stock |
| PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 35.06 per share. | 09 Aug 2021 | 2,198 | 1,802 | - | 35.1 | 77,070 | Common Stock |
| PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 32.66 per share. | 09 Aug 2021 | 2,049 | 224 | - | 32.7 | 66,914 | Common Stock |
| PMV Pharmaceuticals Inc | Leila Alland | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 36.69 per share. | 09 Aug 2021 | 224 | 0 | - | 36.7 | 8,219 | Common Stock |